Perspectives on Reducing Barriers to the Adoption of Digital and Computational Pathology Technology by Clinical Labs

<b>Background/Objectives:</b> Digital and computational pathology (DP/CP) tools have the potential to improve the efficiency and accuracy of the anatomic pathology workflow; however, current adoption among US hospital and reference labs remains low. <b>Methods:</b> To better...

Full description

Saved in:
Bibliographic Details
Main Authors: Jeffrey L. Bessen, Melissa Alexander, Olivia Foroughi, Roderick Brathwaite, Emre Baser, Liam C. Lee, Omar Perez, Gary Gustavsen
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/15/7/794
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850212574028627968
author Jeffrey L. Bessen
Melissa Alexander
Olivia Foroughi
Roderick Brathwaite
Emre Baser
Liam C. Lee
Omar Perez
Gary Gustavsen
author_facet Jeffrey L. Bessen
Melissa Alexander
Olivia Foroughi
Roderick Brathwaite
Emre Baser
Liam C. Lee
Omar Perez
Gary Gustavsen
author_sort Jeffrey L. Bessen
collection DOAJ
description <b>Background/Objectives:</b> Digital and computational pathology (DP/CP) tools have the potential to improve the efficiency and accuracy of the anatomic pathology workflow; however, current adoption among US hospital and reference labs remains low. <b>Methods:</b> To better understand the current utilization of DP/CP technology and barriers to widespread adoption, we conducted a survey among 63 anatomic pathologists and lab directors within the US health system. <b>Results:</b> The survey results indicated that current use cases for DP/CP involve streamlining traditional manual pathology and that labs would have substantial difficulty providing AI-guided image analysis if it were required by physicians today. Among potential catalysts for the broader adoption of DP/CP, pathologists identified clinical guidelines as a key resource for anatomic pathology, whose endorsement of DP/CP would be highly impactful for reducing current barriers. <b>Conclusions:</b> Expanded access to DP/CP may ultimately benefit all major stakeholders—patients, physicians, clinical laboratory professionals, care settings, and payers—and will therefore require collaboration across these groups.
format Article
id doaj-art-ddc58fcd2de944b583b11ba8e37f33c5
institution OA Journals
issn 2075-4418
language English
publishDate 2025-03-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj-art-ddc58fcd2de944b583b11ba8e37f33c52025-08-20T02:09:18ZengMDPI AGDiagnostics2075-44182025-03-0115779410.3390/diagnostics15070794Perspectives on Reducing Barriers to the Adoption of Digital and Computational Pathology Technology by Clinical LabsJeffrey L. Bessen0Melissa Alexander1Olivia Foroughi2Roderick Brathwaite3Emre Baser4Liam C. Lee5Omar Perez6Gary Gustavsen7Health Advances LLC, Newton, MA 02466, USAAstraZeneca, Gaithersburg, MD 20878, USAHealth Advances LLC, Newton, MA 02466, USAAstraZeneca, Gaithersburg, MD 20878, USAAstraZeneca, Gaithersburg, MD 20878, USAAstraZeneca, Gaithersburg, MD 20878, USAAstraZeneca, Gaithersburg, MD 20878, USAHealth Advances LLC, Newton, MA 02466, USA<b>Background/Objectives:</b> Digital and computational pathology (DP/CP) tools have the potential to improve the efficiency and accuracy of the anatomic pathology workflow; however, current adoption among US hospital and reference labs remains low. <b>Methods:</b> To better understand the current utilization of DP/CP technology and barriers to widespread adoption, we conducted a survey among 63 anatomic pathologists and lab directors within the US health system. <b>Results:</b> The survey results indicated that current use cases for DP/CP involve streamlining traditional manual pathology and that labs would have substantial difficulty providing AI-guided image analysis if it were required by physicians today. Among potential catalysts for the broader adoption of DP/CP, pathologists identified clinical guidelines as a key resource for anatomic pathology, whose endorsement of DP/CP would be highly impactful for reducing current barriers. <b>Conclusions:</b> Expanded access to DP/CP may ultimately benefit all major stakeholders—patients, physicians, clinical laboratory professionals, care settings, and payers—and will therefore require collaboration across these groups.https://www.mdpi.com/2075-4418/15/7/794digital and computational pathologyanatomic pathologypathologistslab directorsAI-guided image analysiswhole-slide imaging
spellingShingle Jeffrey L. Bessen
Melissa Alexander
Olivia Foroughi
Roderick Brathwaite
Emre Baser
Liam C. Lee
Omar Perez
Gary Gustavsen
Perspectives on Reducing Barriers to the Adoption of Digital and Computational Pathology Technology by Clinical Labs
Diagnostics
digital and computational pathology
anatomic pathology
pathologists
lab directors
AI-guided image analysis
whole-slide imaging
title Perspectives on Reducing Barriers to the Adoption of Digital and Computational Pathology Technology by Clinical Labs
title_full Perspectives on Reducing Barriers to the Adoption of Digital and Computational Pathology Technology by Clinical Labs
title_fullStr Perspectives on Reducing Barriers to the Adoption of Digital and Computational Pathology Technology by Clinical Labs
title_full_unstemmed Perspectives on Reducing Barriers to the Adoption of Digital and Computational Pathology Technology by Clinical Labs
title_short Perspectives on Reducing Barriers to the Adoption of Digital and Computational Pathology Technology by Clinical Labs
title_sort perspectives on reducing barriers to the adoption of digital and computational pathology technology by clinical labs
topic digital and computational pathology
anatomic pathology
pathologists
lab directors
AI-guided image analysis
whole-slide imaging
url https://www.mdpi.com/2075-4418/15/7/794
work_keys_str_mv AT jeffreylbessen perspectivesonreducingbarrierstotheadoptionofdigitalandcomputationalpathologytechnologybyclinicallabs
AT melissaalexander perspectivesonreducingbarrierstotheadoptionofdigitalandcomputationalpathologytechnologybyclinicallabs
AT oliviaforoughi perspectivesonreducingbarrierstotheadoptionofdigitalandcomputationalpathologytechnologybyclinicallabs
AT roderickbrathwaite perspectivesonreducingbarrierstotheadoptionofdigitalandcomputationalpathologytechnologybyclinicallabs
AT emrebaser perspectivesonreducingbarrierstotheadoptionofdigitalandcomputationalpathologytechnologybyclinicallabs
AT liamclee perspectivesonreducingbarrierstotheadoptionofdigitalandcomputationalpathologytechnologybyclinicallabs
AT omarperez perspectivesonreducingbarrierstotheadoptionofdigitalandcomputationalpathologytechnologybyclinicallabs
AT garygustavsen perspectivesonreducingbarrierstotheadoptionofdigitalandcomputationalpathologytechnologybyclinicallabs